BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 29996150)

  • 1. Molecular Diagnostics in Pediatric Brain Tumors: Impact on Diagnosis and Clinical Decision-Making - A Selected Case Series.
    Bächli H; Ecker J; van Tilburg C; Sturm D; Selt F; Sahm F; Koelsche C; Grund K; Sutter C; Pietsch T; Witt H; Herold-Mende C; von Deimling A; Jones D; Pfister S; Witt O; Milde T
    Klin Padiatr; 2018 Oct; 230(6):305-313. PubMed ID: 29996150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of molecular classification and treatment implications of pediatric brain tumors.
    Guerreiro Stucklin AS; Ramaswamy V; Daniels C; Taylor MD
    Curr Opin Pediatr; 2018 Feb; 30(1):3-9. PubMed ID: 29315108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care.
    Karimi S; Zuccato JA; Mamatjan Y; Mansouri S; Suppiah S; Nassiri F; Diamandis P; Munoz DG; Aldape KD; Zadeh G
    Clin Epigenetics; 2019 Dec; 11(1):185. PubMed ID: 31806041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of the CNS TAP tool for the selection of precision medicine therapies in neuro-oncology.
    Linzey JR; Marini BL; Pasternak A; Smith C; Miklja Z; Zhao L; Kumar-Sinha C; Paul A; Harris N; Robertson PL; Hoffman LM; Chinnaiyan A; Mody R; Koschmann C
    J Neurooncol; 2018 Mar; 137(1):155-169. PubMed ID: 29235051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients.
    Horbinski C; Ligon KL; Brastianos P; Huse JT; Venere M; Chang S; Buckner J; Cloughesy T; Jenkins RB; Giannini C; Stupp R; Nabors LB; Wen PY; Aldape KJ; Lukas RV; Galanis E; Eberhart CG; Brat DJ; Sarkaria JN
    Neuro Oncol; 2019 Dec; 21(12):1498-1508. PubMed ID: 31276167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for DNA methylation based molecular profiling to improve diagnostic accuracy for central nervous system embryonal tumors (not otherwise specified) in adults.
    Halliday GC; Junckerstorff RC; Bentel JM; Miles A; Jones DTW; Hovestadt V; Capper D; Endersby R; Cole CH; van Hagen T; Gottardo NG
    J Clin Neurosci; 2018 Jan; 47():163-167. PubMed ID: 28993028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Screening for Cancer Treatment Optimization (MOSCATO-01) in Pediatric Patients: A Single-Institutional Prospective Molecular Stratification Trial.
    Harttrampf AC; Lacroix L; Deloger M; Deschamps F; Puget S; Auger N; Vielh P; Varlet P; Balogh Z; Abbou S; Allorant A; Valteau-Couanet D; Sarnacki S; Gamiche-Rolland L; Meurice G; Minard-Colin V; Grill J; Brugieres L; Dufour C; Gaspar N; Michiels S; Vassal G; Soria JC; Geoerger B
    Clin Cancer Res; 2017 Oct; 23(20):6101-6112. PubMed ID: 28733441
    [No Abstract]   [Full Text] [Related]  

  • 8. Precision Neuro-oncology: the Role of Genomic Testing in the Management of Adult and Pediatric Gliomas.
    Ramkissoon LA; Britt N; Guevara A; Whitt E; Severson E; Sathyan P; Gay L; Elvin J; Ross JS; Brown C; Stogner-Underwood K; Mott R; Kram D; Strowd R; Lesser GJ; Ramkissoon SH
    Curr Treat Options Oncol; 2018 Jun; 19(8):41. PubMed ID: 29931654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.
    Gajjar A; Bowers DC; Karajannis MA; Leary S; Witt H; Gottardo NG
    J Clin Oncol; 2015 Sep; 33(27):2986-98. PubMed ID: 26304884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.
    Ecker J; Selt F; Sturm D; Sill M; Korshunov A; Hirsch S; Capper D; Dikow N; Sutter C; Müller C; Sigaud R; Eggert A; Simon T; Niehues T; von Deimling A; Pajtler KW; van Tilburg CM; Jones DTW; Sahm F; Pfister SM; Witt O; Milde T
    Eur J Cancer; 2023 Feb; 180():71-84. PubMed ID: 36542877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of genome-wide DNA methylation profiling for pediatric-type diffuse gliomas.
    Otani Y; Satomi K; Suruga Y; Ishida J; Fujii K; Ichimura K; Date I
    Brain Tumor Pathol; 2023 Apr; 40(2):56-65. PubMed ID: 37004583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Diagnostic and Therapeutic Outcomes in Pediatric Brain Tumors.
    Grob ST; Levy JMM
    Mol Diagn Ther; 2018 Feb; 22(1):25-39. PubMed ID: 28900876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Personalized neurooncology].
    Platten M; Steinbach JP; Wick W
    Nervenarzt; 2013 Aug; 84(8):937-42. PubMed ID: 23775285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Genomic Sequencing in Pediatric CNS Tumors.
    Bavle AA; Lin FY; Parsons DW
    Oncology (Williston Park); 2016 May; 30(5):411-23. PubMed ID: 27188671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Neuro-Oncology.
    Malbari F
    Neurol Clin; 2021 Aug; 39(3):829-845. PubMed ID: 34215389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact.
    Drexler R; Brembach F; Sauvigny J; Ricklefs FL; Eckhardt A; Bode H; Gempt J; Lamszus K; Westphal M; Schüller U; Mohme M
    Acta Neuropathol Commun; 2024 Jan; 12(1):9. PubMed ID: 38229158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal molecular analysis of astroblastoma enables reclassification of most cases into more specific molecular entities.
    Wood MD; Tihan T; Perry A; Chacko G; Turner C; Pu C; Payne C; Yu A; Bannykh SI; Solomon DA
    Brain Pathol; 2018 Mar; 28(2):192-202. PubMed ID: 28960623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.
    Katsila T; Matsoukas MT; Patrinos GP; Kardamakis D
    OMICS; 2017 Aug; 21(8):429-439. PubMed ID: 28816643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial.
    Bonneville-Levard A; Frappaz D; Tredan O; Lavergne E; Corset V; Agrapart V; Chabaud S; Pissaloux D; Wang Q; Attignon V; Cartalat S; Ducray F; Thomas-Maisonneuve L; Honnorat J; Meyronet D; Taillandier L; Blonski M; Viari A; Baudet C; Sohier E; Lantuejoul S; Paindavoine S; Treilleux I; Rodriguez C; Pérol D; Blay JY
    Med Oncol; 2021 Nov; 39(1):4. PubMed ID: 34739635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Personalized therapy for gliomas].
    Wick W; Hau P
    Nervenarzt; 2015 Jun; 86(6):692, 694-6, 698-700. PubMed ID: 26022855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.